Home › Funds › WORLDQUANT MILLENNIUM ADVISORS LLC › ABT

WORLDQUANT MILLENNIUM ADVISORS LLC position in ABT

ABBOTT LABORATORIES · Health Care

WORLDQUANT MILLENNIUM ADVISORS LLC reported holding 2,224,023 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$201.8M, representing 0.69% of its reported portfolio and ranking #25 among its reported holdings. WORLDQUANT MILLENNIUM ADVISORS LLC has disclosed ABT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.22M sh
Reported value held$201.81M
Portfolio Weight0.69%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How WORLDQUANT MILLENNIUM ADVISORS LLC's ABT position evolved

WORLDQUANT MILLENNIUM ADVISORS LLC first disclosed a stake in ABT in Q3 2023 at 317,752 shares (US$30.8M). The position peaked in Q2 2026 at 2,224,023 shares, worth US$201.8M. Across 10 filings, WORLDQUANT MILLENNIUM ADVISORS LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,224,023 shares valued at US$201.8M — an increase of 763,062 shares quarter over quarter.. Notable position changes include a 80% trim in Q1 2024 (shares fell 8% over the following quarter), a 5039% increase in Q2 2024 (shares rose 10% over the following quarter), a 355% increase in Q1 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 317.75K $30.77M New
Q4 2023 92.43K $10.17M Reduce
Q1 2024 18.62K $2.12M Reduce
Q2 2024 956.77K $99.42M Add
Q3 2024 713.39K $81.33M Reduce
Q4 2024 484.02K $54.75M Reduce
Q1 2025 259.02K $34.36M Reduce
Q4 2025 321.28K $40.25M New
Q1 2026 1.46M $150.00M Add
Q2 2026 2.22M $201.81M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has WORLDQUANT MILLENNIUM ADVISORS LLC held ABT?

WORLDQUANT MILLENNIUM ADVISORS LLC has disclosed ABT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

What is WORLDQUANT MILLENNIUM ADVISORS LLC's current position in ABT?

As of Q2 2026, WORLDQUANT MILLENNIUM ADVISORS LLC holds 2.22M shares of ABT (ABBOTT LABORATORIES), valued at $201.81M, representing 0.69% of its reported portfolio and ranking #25.

Has WORLDQUANT MILLENNIUM ADVISORS LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), WORLDQUANT MILLENNIUM ADVISORS LLC increased its position in ABT. The position peaked in Q2 2026 at 2.22M shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.